Identity
- Trade Name
- ΧΟΛΗΣΤΕΡΟΛΗ LIQUID 6x36 ml (GSAU) EUDAMED
- Device Name
- ΧΟΛΗΣΤΕΡΟΛΗ LIQUID 6x36 ml (GSAU) EUDAMED
- Model / Reference
- 002158 EUDAMED
Identifiers
- Primary DI / UDI-DI
- 05213003193432 EUDAMED
- Basic UDI-DI
- B-05213003193432 EUDAMED
- EMDN Code
- W01010205 CHOLESTEROL EUDAMED
Classification
- Device Class
- Class IVD General EUDAMED
- Market of Registration
- Greece EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Microbial Substances
No
EUDAMED
Reagent
Yes
EUDAMED
Self Testing
No
EUDAMED
Near-Patient Testing
No
EUDAMED
Professional Testing
Yes
EUDAMED
Companion Diagnostics
No
EUDAMED
Surgical Instrument
No
EUDAMED
Category: Total cholesterol lipid IVD, reagent
ΧΟΛΗΣΤΕΡΟΛΗ LIQUID 6x36 ml (GSAU) by Biotechnological Applications Ltd — Class IVD General — IVDD — listed in EUDAMED — regulatory data on deviCERTS
Similar devices
Also classified as Total cholesterol lipid IVD, reagent.
- FORA — FORA CARE INC. · Class I
- OS-CHOL — PZ CORMAY Spółka Akcyjna · IVD General
- Cholesterol (CHOL) Assay Kit (Oxidase Method) — YHLO BIOTECH (NANJING) CO., LTD. · IVD General
- HeartsCare C1 Total Cholesterol Test Strip (10pcs/box) — Hearts Bio, Inc. · Class I
- Teco Diagnostics Cholesterol TC-Matrix-480 — TECO DIAGNOSTICS · Class I
- DIRUI — DIRUI INDUSTRIAL CO., LTD · IVD General
- Liquick Cor-CHOL 30 — PZ CORMAY Spółka Akcyjna · IVD General
- Total Cholesterol (TC) — Maccura Biotechnology Co., Ltd. · IVD General
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/IVDD
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/IVDD | B-05213003193432 | Class IVD General | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Biotechnological Applications Ltd
- EUDAMED SRN
- GR-MF-000033000
Sources (1)
- EUDAMED c7a3dc4a-ca5f-4d1f-b5bd-0b18838165ec 61 fields · synced Jun 19, 2026